For research use only · Not for human consumption
This material is reference information for laboratory study of research peptides. It is not medical advice and it is not instructions for human use, self-administration, or therapeutic application. Capital Peptides supplies research chemicals for in-vitro and animal-model study only. Discuss any health-related questions with a licensed medical practitioner.
1Side-by-side comparison
| Peptides | Anabolic Steroids | SARMs | Supplements | Pharmaceuticals | |
|---|---|---|---|---|---|
| Chemical class | Amino acid chains | Cholesterol derivatives | Synthetic small molecules | Varies widely | Varies — approved drugs |
| How they work | Receptor signalling (specific) | Androgen receptor (broad) | Androgen receptor (selective) | Varies | Varies by drug class |
| HPTA suppression | Generally none | Yes — significant | Yes — moderate | No | Depends |
| Aromatisation | No | Yes (most) | No | No | Depends |
| Injectable required | Usually yes | Often yes | No (oral) | No | Depends |
| WADA banned | Some | Yes — all | Yes — all | Some | Depends |
| Legal status (AU) | Research use | Prescription only | Research use | OTC/TGA listed | Prescription / OTC |
| Human trial data | Limited–moderate | Extensive | Limited | Varies | Extensive |
| Reversibility | High — clears fast | Moderate — slow clearance | Moderate | High | Depends |
2Peptides vs. anabolic steroids
Anabolic-androgenic steroids (AAS) are synthetic derivatives of testosterone. They bind to androgen receptors throughout the body — muscle, liver, brain, prostate, hair follicles — producing both anabolic (muscle-building) and androgenic (masculinising) effects. The receptor binding is broad and non-selective.
Key differences:
- HPTA suppression: Exogenous androgens tell the hypothalamus and pituitary to shut down natural testosterone production. Recovery after a cycle can take months. Peptides generally don't cause this.
- Aromatisation: Many steroids convert to oestrogen, causing gynecomastia and water retention. Peptides don't aromatise.
- Half-life and detection: Some steroids remain detectable for months. Most peptides clear within hours to days.
- Research purpose: GH secretagogue peptides are often used instead of anabolic steroids by those seeking body composition changes with a lower androgenic side-effect profile.
Note: Some people confuse HGH (human growth hormone, a 191-amino-acid peptide) with anabolic steroids. HGH is a peptide, not a steroid — but it's a pharmaceutical-grade hormone with its own distinct risk profile, different from the research peptides sold here.
3Peptides vs. SARMs
Selective androgen receptor modulators (SARMs) were designed to deliver androgen-receptor activation in muscle and bone while minimising effects on other tissues. They are synthetic small molecules — not peptides — and they do still interact with the androgen axis.
Key differences:
- Mechanism: SARMs act on the androgen receptor (same as testosterone, just more selectively). Most peptides act on entirely different receptor systems (GH-axis, healing pathways, melanocortin, etc.).
- HPTA suppression: SARMs cause partial HPTA suppression in a dose-dependent way — less than full AAS, but not zero. Peptides generally do not.
- Oral availability: Most SARMs are taken orally. Most research peptides require subcutaneous injection due to digestive degradation.
- Liver toxicity: Some SARMs show hepatotoxicity signals in case reports. This is not a known concern for most peptides.
4Peptides vs. supplements
Supplements (protein powders, creatine, vitamins, pre-workouts) are generally food-derived or physiologically low-dose compounds sold OTC. The comparison is mostly about expectations:
- Supplements work within normal physiological bounds. Peptides can produce supraphysiological signalling effects.
- Supplements have very broad safety profiles. Peptides have narrower windows and more specific contraindications.
- Supplements don't require reconstitution, sterile injection technique, or sourcing from research vendors.
- The effect magnitude and speed of action are generally different categories. A research peptide is not a “stronger supplement.”
5Peptides vs. pharmaceuticals
Some peptides are pharmaceuticals — semaglutide (Ozempic/Wegovy), tirzepatide (Mounjaro), and teriparatide are approved drugs that happen to be peptides. The distinction relevant here is between approved drugs with full clinical trial programmes and research-use compounds without regulatory approval.
- Pharmaceutical peptides have gone through Phase I–III trials establishing safety, efficacy, dosing, and contraindications in tens of thousands of patients.
- Research peptides have varying evidence bases — from well-characterised animal data + human case reports (BPC-157) to very limited data (some newer nootropic peptides).
- Research peptides are not manufactured under pharmaceutical GMP. Purity and sterility standards vary by vendor.
6Where peptides fit
Research peptides occupy a distinct category:
- More pharmacologically active than supplements
- Less well-characterised than approved pharmaceuticals
- Mechanistically different from steroids and SARMs
- Used for specific research goals (healing, GH axis, cognitive function, fat loss) that have limited pharmaceutical alternatives
The appropriate frame is: a pharmacologically active investigational compound that warrants the same respect as any medication — careful dosing, health screening, monitoring, and sourcing diligence.